Please provide your email address to receive an email when new articles are posted on . Patients taking antihypertensive drugs had a higher incidence rate of eczematous dermatitis. Diuretic drugs and ...

USA: Researchers have discovered in a new research that compared with angiotensin II–inhibiting antihypertensives, angiotensin II–stimulating medications were associated with a lower risk of certain ...

Cone-beam computed tomography (CBCT) scans show antihypertensive drugs may positively affect the thickness of the jawbone cortex, possibly preventing bone loss. The study was published April 4 in Oral ...

Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...

Please provide your email address to receive an email when new articles are posted on . The 5-year risk for developing acne was significantly lower among adults taking vasodilators vs. thiazide ...

Antihypertensive medications, which are used to treat high blood pressure, are associated with an increased risk for eczema in older adults, a new study finds. The effects were biggest among people ...

Antihypertensives that stimulate angiotensin II receptors are associated with a lower risk for biomarkers of dementia.

LOS ANGELES -- Use of angiotensin receptor blockers (ARBs) was linked to a lower risk of epilepsy after an acute ischemic stroke, according to an observational study. Among hypertensive patients, ARB ...

In treating hypertension to blood pressure goal levels, undue orthostatic hypotension sometimes occurs. Is there an agent or class of antihypertensive agents more or less likely to cause this effect?

Obstructive sleep apnea (OSA), a common complication of obesity, plays an important role in the development of hypertension. Mechanisms include intermittent hypoxia, oxidative stress, increased ...

Introduction Hypertension programmes have expanded substantially in low-income and middle-income countries, yet treatment and control rates remain insufficient. Programme scale-up may lead to ...